The initial data on a trial of the coronavirus vaccine being developed by Oxford University will be released in the coming week, The Lancet medical journal has announced amid reports its findings have been promising.
The development of a vaccine to fight against the virus has been touted as pivotal in returning the world to life as it was before the pandemic by protecting vulnerable people and building up immunity among populations.
Now Oxford University’s contribution – one of the world’s leading candidates for a viable vaccine – is understood to have made promising results in initial testing.
While falling short of proving it will work with complete certainty, phase one of the trial is understood to have shown the vaccine prompts an immune response from those tested – according to The Daily Telegraph.
Blood samples are reported to have shown up both antibodies and T-cells required to fight off the virus, the paper added.